Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 BridgeBio PharmaMirati TherapeuticsUnited TherapeuticsAlkermesUltragenyx Pharmaceutical
SymbolNASDAQ:BBIONASDAQ:MRTXNASDAQ:UTHRNASDAQ:ALKSNASDAQ:RARE
Price Information
Current Price$24.75$91.61$84.20$21.48$43.54
52 Week RangeBuyBuyHoldHoldBuy
Analyst Ratings
Consensus RecommendationBuyBuyHoldHoldBuy
Consensus Price Target$40.1250$102.6114$125.30$28.70$74.3333
% Upside from Price Target62.12% upside12.01% upside48.81% upside33.61% upside70.72% upside
Trade Information
Market Cap$2.89 billion$3.36 billion$3.54 billion$3.38 billion$2.54 billion
BetaN/A2.070.911.822.13
Average Volume234,356657,966541,4631,143,673545,066
Sales & Book Value
Annual RevenueN/A$12.93 million$1.63 billion$1.09 billion$51.49 million
Price / SalesN/A278.442.273.0848.78
CashflowN/AN/A$14.9556 per share$0.5960 per shareN/A
Price / CashN/AN/A5.6336.04N/A
Book ValueN/A$5.86 per share$63.98 per share$7.54 per share$12.04 per share
Price / BookN/A15.631.322.853.62
Profitability
Net IncomeN/A$-98,420,000.00$589.20 million$-139,310,000.00$-197,610,000.00
EPSN/A($3.19)$13.39($0.07)($7.39)
Trailing P/E Ratio0.00N/A6.29N/AN/A
Forward P/E RatioN/AN/A9.00N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-7.69%-17.10%-527.49%
Return on Equity (ROE)N/A-48.18%-4.54%-4.13%-49.84%
Return on Assets (ROA)N/A-44.27%-3.26%-2.63%-43.01%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.31%0.25%0.04%
Current RatioN/A17.57%4.62%2.98%9.32%
Quick RatioN/A17.57%4.41%2.69%9.14%
Ownership Information
Institutional Ownership Percentage85.33%N/A94.11%95.90%N/A
Insider Ownership PercentageN/A4.70%8.80%4.71%7.80%
Miscellaneous
Employees152638602,300N/A
Shares Outstanding120.50 million39.30 million43.85 million157.13 million57.69 million
Next Earnings DateN/A11/5/2019 (Estimated)10/30/2019 (Estimated)10/22/2019 (Estimated)11/4/2019 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableOptionable
 BridgeBio PharmaMirati TherapeuticsUnited TherapeuticsAlkermesUltragenyx Pharmaceutical

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel